Clinical Trials Logo

Nervous System Diseases clinical trials

View clinical trials related to Nervous System Diseases.

Filter by:

NCT ID: NCT00300222 Completed - Pain Clinical Trials

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy and safety of NGX-4010 applied for 60 minutes for the treatment of postherpetic neuralgia (PHN).

NCT ID: NCT00291421 Completed - Alzheimer Disease Clinical Trials

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

Start date: July 2002
Phase: N/A
Study type: Observational

The purpose of this study is to collect and compare information regarding the treatment and outcome of patients diagnosed with Alzheimer's disease who are receiving either drug or nondrug treatment. Information will be collected from patients and their primary caregivers.

NCT ID: NCT00270842 Completed - Clinical trials for Diabetic Neuropathies

Effect of Exercise on Gait and Balance in Peripheral Neuropathy

Start date: January 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if participation in one of the study groups: functional balance training, Tai Chi, or education, results in better outcomes overall. The outcomes that we are primarily interested in are related to walking ability and balance.

NCT ID: NCT00240695 Completed - Mental Disorders Clinical Trials

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Start date: May 2003
Phase: Phase 3
Study type: Interventional

The purpose of this follow-up study is to assess the long-term safety and tolerability of galantamine in individuals with mild cognitive impairment who participated in a previous study with galantamine

NCT ID: NCT00233155 Completed - Pain Clinical Trials

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

Start date: August 2005
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of NGX-4010 administered at intervals of no less than 12 weeks over 1 year, based on the presence or return of pain, for the treatment of painful HIV-AN and PHN. Participation is limited to former study subjects from previous trials of NGX-4010 at selected sites.

NCT ID: NCT00122174 Completed - Parkinson's Disease Clinical Trials

Stress-Busting Program for Caregivers of Patients With Neruological Diseases

Start date: July 2004
Phase: N/A
Study type: Interventional

Although family caregivers perform an incredibly valuable service for their relatives and the formal health care system, they do so at a considerable cost to themselves both emotionally and physically. Effective stress management techniques can: 1) help to decrease the caregivers' feelings of burden and stress; 2) improve the emotional and physical health of caregivers; and 3) empower caregivers to gain control of their lives.

NCT ID: NCT00116337 Completed - Clinical trials for Spinal Cord Injuries

Spinal Cord Stimulation to Restore Cough

Start date: September 30, 2004
Phase: N/A
Study type: Interventional

The purpose of this trial is to determine the efficacy of spinal cord stimulation to produce an effective cough in patients with spinal cord injuries.

NCT ID: NCT00116207 Completed - Clinical trials for Diabetic Autonomic Neuropathy

An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes

Start date: January 2000
Phase: Phase 3
Study type: Interventional

The focus of this project is cardiovascular diabetic autonomic neuropathy (DAN). DAN affects the nerves that control heart rate and blood flow to the heart in people with diabetes. DAN may cause problems with the rhythm of the heartbeat or decrease blood flow to the heart. Three medications will be tested for their effectiveness in DAN.

NCT ID: NCT00115310 Completed - Pain Clinical Trials

Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy and safety of NGX-4010 applied for 60 minutes for the treatment of postherpetic neuralgia (PHN).

NCT ID: NCT00110331 Completed - HIV Infections Clinical Trials

Central Nervous System Disease in HIV-infected Children on HAART

Start date: May 3, 2005
Phase:
Study type: Observational

This study will examine how HIV affects the brain and nervous system, learning, and behavior in children on highly active antiretroviral therapy (HAART). Although HAART has resulted in fewer HIV-infected children getting sick and even fewer dying from AIDS, many children on this treatment regimen develop significant brain or nervous system problems, such as learning difficulties, attention problems, hyperactivity, and depression. People who acquired HIV disease in the first decade of life and who have evidence of central nervous system (CNS) disease (e.g., encephalopathy, CNS compromise, ADHD, bipolar disease, major depression or psychosis) may be eligible for this study. Candidates are screened with a medical history, physical examination, neuropsychological testing and a CT scan of the head, if one has not been done within 12 months of entering the study. Participants undergo the following tests and procedures: - MRI and MRS scan of the head: These tests use a magnetic field and radio waves to obtain images of the brain and detect changes in certain brain chemicals that may be affected by HIV infection. Both procedures are done at the same time. The patient lies on a table that is moved into the scanner (a narrow cylinder), wearing earplugs to muffle loud knocking and thumping sounds that occur during the scanning process. The procedure lasts about 50 to 60 minutes, during which time the patient can communicate with the staff. - Neuropsychological testing: Patients' thinking and behavior are evaluated with tests to measure their memory, attention, language, problem-solving, academic, and motor skills and questionnaires to assess behavioral and emotional functioning, quality of life, and adherence to HIV medication. Parents are also asked to complete questionnaires assessing their child's behavioral and emotional functioning, quality of life, important life events, and adherence to HIV medication. - Lumbar puncture (spinal tap): Cerebrospinal fluid (CSF) is collected for analysis. For this procedure, a local anesthetic is given and a needle is inserted in the space between the bones in the lower back where the CSF circulates below the spinal cord. Some fluid is collected through the needle. Blood tests and a physical examination are done before the procedure to make sure it can be done as safely as possible. Patients may also be sedated to prevent any discomfort. - Follow-up: The blood tests, MRI and MRS scans and spinal tap are repeated 1 and 2 years after the initial evaluation. Some blood and spinal fluid samples from participants are stored for possible future studies related to HIV research